Personalized brain cancer vax tested in humans

An experimental brain cancer vaccine developed at Duke University is being tested on patients at Duke and St. Vincent's Medical Center in Jacksonville, FL. The vaccine is made by extracting white blood cells from the patient and then mixing it with DNA that includes the genetic mutations that triggered the glioblastoma. "We think a significant reason these tumors are so hard to treat to begin with is they are so good at evading the immune system," said Kent New, the head of neurosurgery at an affiliate of St. Vincent's. New trained with Duke's John Sampson, who developed the personalized vaccine. Report

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.